FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Karin Milde-Langosch

Research Profile

Disorders

Procedures

Phenomena

Blotting, Western

Living Beings

Papillomaviridae

Chemicals & Drugs

Physiology

Gene Expression Regulation, Neoplastic

Concepts & Ideas

Disease-Free Survival

Co-author Network

Publications

TOP 3
Isabell Witzel; Monika Graeser; Fritz Jänicke; Thomas Karn; Karin Milde-Langosch; Alma Rausch; Markus Schmidt; Dina Schütze; Ralph Wirtz; Volkmar Müller
Androgen receptor expression is a predictive marker in chemotherapy-treated patients with endocrine receptor-positive primary breast cancers.
Dina Schütze; Isabell Witzel; Achim Rody; Marcus Schmidt; Matthias Choschzick; Fritz Jänicke; Thomas Karn; Karin Milde-Langosch; Volkmar Müller
Relevance of cellular and serum carbonic anhydrase IX in primary breast cancer.
Karin Milde-Langosch; Volkmar Müller; Achim Rody; Markus Schmidt; Thomas Karn; Isabell Witzel; Ralph M Wirtz
Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Karin Milde-Langosch (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Isabell Witzel; Monika Graeser; Fritz Jänicke; Thomas Karn; Karin Milde-Langosch; Alma Rausch; Markus Schmidt; Dina Schütze; Ralph Wirtz; Volkmar Müller
Androgen receptor expression is a predictive marker in chemotherapy-treated patients with endocrine receptor-positive primary breast cancers.
Journal of cancer research and clinical oncology 2013;139(5):809-16.
2013: Dina Schütze; Isabell Witzel; Achim Rody; Marcus Schmidt; Matthias Choschzick; Fritz Jänicke; Thomas Karn; Karin Milde-Langosch; Volkmar Müller
Relevance of cellular and serum carbonic anhydrase IX in primary breast cancer.
Journal of cancer research and clinical oncology 2013;139(5):747-54.
2013: Karin Milde-Langosch; Volkmar Müller; Achim Rody; Markus Schmidt; Thomas Karn; Isabell Witzel; Ralph M Wirtz
Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer.
Breast cancer research and treatment 2013;137(1):57-67.
2013: Virginia Dippel; Fritz Jänicke; Karin Milde-Langosch; Leticia Oliveira-Ferrer; Udo Schumacher; Daniel Wicklein; Peter Altevogt; Christine Schröder
Influence of L1-CAM expression of breast cancer cells on adhesion to endothelial cells.
Journal of cancer research and clinical oncology 2013;139(1):107-21.
2012: Heidi Schwarzenbach; Bettina Steinbach; Karin Milde-Langosch; Volkmar Müller; Klaus Pantel
Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients.
Breast cancer research and treatment 2012;134(3):933-41.
2012: Harriet Wikman; Isabell Witzel; Guido Sauter; Bettina Sielaff-Frimpong; Manfred Westphal; Jolanthe Kropidlowski; Katrin Lamszus; Karin Milde-Langosch; Klaus Pantel
Clinical relevance of loss of 11p15 in primary and metastatic breast cancer: association with loss of PRKCDBP expression in brain metastases.
PloS one 2012;7(10):e47537.
2012: Isabell Witzel; Hilke Zander; Maike Ihnen; Fritz Jänicke; Volkmar Müller; Christine Schröder; Michael Tachezy; Karin Milde-Langosch
Detection of activated leukocyte cell adhesion molecule in the serum of breast cancer patients and implications for prognosis.
Oncology 2012;82(6):305-12.
2012: Maike Ihnen; Fritz Jänicke; Jan Felix Kersten; Ergin Kilic; Kerstin Kress; Sven Mahner; Volkmar Müller; Linn Woelber; Hilke Zander; Matthias Choschzick; Karin Milde-Langosch
Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients.
BMC cancer 2012;12():140.
2011: Heidi Schwarzenbach; Bettina Steinbach; Karin Milde-Langosch; Volkmar Müller; Klaus Pantel
Evaluation of cell-free tumour DNA and RNA in patients with breast cancer and benign breast disease.
Molecular bioSystems 2011;7(10):2848-54.
2011: Sibyll Hein; Maike Ihnen; Rana Issa; Fritz Jänicke; Nadine Köhler; Sylke Krenkel; Volkmar Müller; Klaus Pantel; Sabine Riethdorf; Michaela Schweizer; Thomas Streichert; Harriet Wikman; Volker Assmann; Katrin Beck; Karin Milde-Langosch
Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
Breast cancer research and treatment 2011;129(2):347-60.
2011: Christine Schröder; Udo Schumacher; Ralph M Wirtz; Isabell Witzel; Fritz Jänicke; Sylke Krenkel; Volkmar Müller; Karin Milde-Langosch
Prognostic value of intercellular adhesion molecule (ICAM)-1 expression in breast cancer.
Journal of cancer research and clinical oncology 2011;137(8):1193-201.
2011: Maike Ihnen; Ergin Kilic; Nadine Köhler; Thomas Löning; Isabell Witzel; Christian Hagel; Sylvia Höller; Jan F Kersten; Volkmar Müller; Fritz Jänicke; Karin Milde-Langosch
Protein expression analysis of ALCAM and CEACAM6 in breast cancer metastases reveals significantly increased ALCAM expression in metastases of the skin.
Journal of clinical pathology 2011;64(2):146-52.
2011: Isabell Witzel; Eva Johanna Kantelhardt; Karin Milde-Langosch; Maike Ihnen; Julia Zeitz; Nadia Harbeck; Fritz Jänicke; Volkmar Müller
Management of patients with brain metastases receiving trastuzumab treatment for metastatic breast cancer.
Onkologie 2011;34(6):304-8.
2011: Lilli Kock; Sven Mahner; Matthias Choschzick; Christine Eulenburg; Karin Milde-Langosch; Jörg Schwarz; Fritz Jaenicke; Volkmar Müller; Linn Woelber
Serum carbonic anhydrase IX and its prognostic relevance in vulvar cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2011;21(1):141-8.
2011: Linn Woelber; Kerstin Kress; Jan F Kersten; Matthias Choschzick; Ergin Kilic; Uwe Herwig; Christoph Lindner; Jörg Schwarz; Fritz Jaenicke; Sven Mahner; Karin Milde-Langosch; Volkmar Mueller; Maike Ihnen
Carbonic anhydrase IX in tumor tissue and sera of patients with primary cervical cancer.
BMC cancer 2011;11():12.
2010: Isabell Witzel; Karin Milde-Langosch; Ralph M Wirtz; Claudia Roth; Maike Ihnen; Sven Mahner; Christine Zu Eulenburg; Fritz Jänicke; Volkmar Müller
Comparison of microarray-based RNA expression with ELISA-based protein determination of HER2, uPA and PAI-1 in tumour tissue of patients with breast cancer and relation to outcome.
Journal of cancer research and clinical oncology 2010;136(11):1709-18.
2010: M Ihnen; R M Wirtz; K T Kalogeras; Karin Milde-Langosch; Martina Schmidt; Isabell Witzel; A G Eleftheraki; C Papadimitriou; Fritz Jänicke; E Briassoulis; D Pectasides; A Rody; G Fountzilas; Volkmar Müller
Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer.
British journal of cancer 2010;103(7):1048-56.
2010: Christine Schröder; Udo Schumacher; Volkmar Müller; Ralph M Wirtz; Thomas Streichert; Ulrich Richter; Daniel Wicklein; Karin Milde-Langosch
The transcription factor Fra-2 promotes mammary tumour progression by changing the adhesive properties of breast cancer cells.
European journal of cancer (Oxford, England : 1990) 2010;46(9):1650-60.
2010: Linn Woelber; Volkmar Mueller; Christine Eulenburg; Jörg Schwarz; Walter Carney; Fritz Jaenicke; Karin Milde-Langosch; Sven Mahner
Serum carbonic anhydrase IX during first-line therapy of ovarian cancer.
Gynecologic oncology 2010;117(2):183-8.
2010: Sven Mahner; Linn Woelber; Christine Eulenburg; Jörg Schwarz; Walter Carney; Fritz Jaenicke; Karin Milde-Langosch; Volkmar Mueller
TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients.
BMC cancer 2010;10():139.
2009: Christine Schröder; Udo Schumacher; Mina Fogel; Friedrich Feuerhake; Volkmar Müller; Ralph M Wirtz; Peter Altevogt; Sylke Krenkel; Fritz Jänicke; Karin Milde-Langosch
Expression and prognostic value of L1-CAM in breast cancer.
Oncology reports 2009;22(5):1109-17.
2009: Sibyll Hein; Sven Mahner; Christine Kanowski; Thomas Löning; Fritz Jänicke; Karin Milde-Langosch
Expression of Jun and Fos proteins in ovarian tumors of different malignant potential and in ovarian cancer cell lines.
Oncology reports 2009;22(1):177-83.
2009: Stefan Knippen; Thomas Löning; Volkmar Müller; Christine Schröder; Fritz Jänicke; Karin Milde-Langosch
Expression and prognostic value of activating transcription factor 2 (ATF2) and its phosphorylated form in mammary carcinomas.
Anticancer research 2009;29(1):183-9.
2008: M Ihnen; Volkmar Müller; R M Wirtz; C Schröder; Sylke Krenkel; Isabell Witzel; B W Lisboa; Fritz Jänicke; Karin Milde-Langosch
Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer.
Breast cancer research and treatment 2008;112(3):419-27.
2008: Nadia Harbeck; Inko Nimmrich; Arndt Hartmann; Jeffrey S Ross; Tanja Cufer; Robert Grützmann; Glen Kristiansen; angelo paradiso; Oliver Hartmann; Astrid Margossian; John Martens; Ina Schwope; Antje Lukas; Volkmar Müller; Karin Milde-Langosch; Jörg Nährig; John A Foekens; Sabine Maier; Manfred Schmitt; Ralf Lesche
Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(31):5036-42.
2008: Sven Mahner; C Baasch; Jörg Schwarz; S Hein; L Wölber; Fritz Jänicke; Karin Milde-Langosch
C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma.
British journal of cancer 2008;99(8):1269-75.
2008: Jens Panse; K Friedrichs; A Marx; Y Hildebrandt; T Luetkens; K Barrels; C Horn; T Stahl; Y Cao; Karin Milde-Langosch; A Niendorf; Nicolaus Kröger; Sören Wenzel; Rudolf Leuwer; Carsten Bokemeyer; Susanna Hegewisch-Becker; Djordje Atanackovic
Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients.
British journal of cancer 2008;99(6):930-8.
2008: Juliane Briese; Heinrich M Schulte; Maria Sajin; Christoph Bamberger; Katja Redlin; Karin Milde-Langosch; Thomas Löning; Ana-Maria Bamberger
Correlations between reduced expression of the metastasis suppressor gene KAI-1 and accumulation of p53 in uterine carcinomas and sarcomas.
Virchows Archiv : an international journal of pathology 2008;453(1):89-96.
2008: Karin Milde-Langosch; Stanislava Janke; Ines Wagner; Christine Schröder; Thomas Streichert; Ana-Maria Bamberger; Fritz Jänicke; Thomas Löning
Role of Fra-2 in breast cancer: influence on tumor cell invasion and motility.
Breast cancer research and treatment 2008;107(3):337-47.
2007: Katharina Blonski; Karin Milde-Langosch; Ana-Maria Bamberger; Tina Osterholz; Christian Utler; Jürgen Berger; Thomas Löning; Udo Schumacher
Ulex europeus agglutinin-I binding as a potential prognostic marker in ovarian cancer.
Anticancer research 2007;27(4C):2785-90.
2006: Nicolaus Kröger; Karin Milde-Langosch; Sabine Riethdorf; Claudia Schmoor; Martin Schumacher; Axel R Zander; Thomas Löning
Prognostic and predictive effects of immunohistochemical factors in high-risk primary breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(1):159-68.
2005: Karin Milde-Langosch
The Fos family of transcription factors and their role in tumourigenesis.
European journal of cancer (Oxford, England : 1990) 2005;41(16):2449-61.
2005: Karin Milde-Langosch; Ana-Maria Bamberger; Gabriele Rieck; D Grund; G Hemminger; V Müller; Thomas Löning
Expression and prognostic relevance of activated extracellular-regulated kinases (ERK1/2) in breast cancer.
British journal of cancer 2005;92(12):2206-15.
2004: Christoph M Bamberger; T Else; I Ellebrecht; Karin Milde-Langosch; D Pankoke; Frank U Beil; Ana-Maria Bamberger
Vitamin B6 modulates glucocorticoid-dependent gene transcription in a promoter- and cell type-specific manner.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2004;112(10):595-600.
2004: Yvonne Pohnke; Tanja Schneider-Merck; Jasmin Fahnenstich; Rita Kempf; Mark Christian; Karin Milde-Langosch; Jan J Brosens; Birgit Gellersen
Wild-type p53 protein is up-regulated upon cyclic adenosine monophosphate-induced differentiation of human endometrial stromal cells.
The Journal of clinical endocrinology and metabolism 2004;89(10):5233-44.
2004: Karin Milde-Langosch; Heike Röder; Birte Andritzky; Bahriye Aslan; Gabriele Hemminger; Anja Brinkmann; Christoph M Bamberger; Thomas Löning; Ana-Maria Bamberger
The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas.
Breast cancer research and treatment 2004;86(2):139-52.
2004: Ana-Maria Bamberger; Christoph M Bamberger; Solveigh Aupers; Karin Milde-Langosch; Thomas Löning; Antonis Makrigiannakis
Expression pattern of the activating protein-1 family of transcription factors in the human placenta.
Molecular human reproduction 2004;10(4):223-8.
2004: Ana-Maria Bamberger; Antonis Makrigiannakis; Martina Schröder; Christoph M Bamberger; Constantine Relakis; Birgit Gellersen; Karin Milde-Langosch; Thomas Löning
Expression pattern of the CCAAT/enhancer-binding proteins C/EBP-alpha, C/EBP-beta and C/EBP-delta in the human placenta.
Virchows Archiv : an international journal of pathology 2004;444(2):149-52.
2003: Richard Ivell; Marga Balvers; Yvonne Pohnke; Ralph Telgmann; Olaf Bartsch; Karin Milde-Langosch; Ana-Maria Bamberger; Almuth Einspanier
Immunoexpression of the relaxin receptor LGR7 in breast and uterine tissues of humans and primates.
Reproductive biology and endocrinology : RB&E 2003;1():114.
2003: Jasmin Fahnenstich; Andreas Nandy; Karin Milde-Langosch; Tanja Schneider-Merck; Norbert Walther; Birgit Gellersen
Promyelocytic leukaemia zinc finger protein (PLZF) is a glucocorticoid- and progesterone-induced transcription factor in human endometrial stromal cells and myometrial smooth muscle cells.
Molecular human reproduction 2003;9(10):611-23.
2003: A Nandy; Susanne Jenatschke; B Hartung; Karin Milde-Langosch; Ana-Maria Bamberger; Birgit Gellersen
Genomic structure and transcriptional regulation of the human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase gene.
Journal of molecular endocrinology 2003;31(1):105-21.
2003: Karin Milde-Langosch; Sabine Riethdorf
Role of cell-cycle regulatory proteins in gynecological cancer.
Journal of cellular physiology 2003;196(2):224-44.
2003: Karin Milde-Langosch; Thomas Löning; Ana-Maria Bamberger
Expression of the CCAAT/enhancer-binding proteins C/EBPalpha, C/EBPbeta and C/EBPdelta in breast cancer: correlations with clinicopathologic parameters and cell-cycle regulatory proteins.
Breast cancer research and treatment 2003;79(2):175-85.
2003: Karin Milde-Langosch; Maria Hagen; Ana-Maria Bamberger; Thomas Löning
Expression and prognostic value of the cell-cycle regulatory proteins, Rb, p16MTS1, p21WAF1, p27KIP1, cyclin E, and cyclin D2, in ovarian cancer.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2003;22(2):168-74.
2003: Ana-Maria Bamberger; Solveig Aupers; Karin Milde-Langosch; Thomas Löning
Expression pattern of the cell cycle promoter cyclin e in benign extravillous trophoblast and gestational trophoblastic lesions: correlation with expression of Ki-67.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2003;22(2):156-61.
2003: Karin Milde-Langosch; Holger Kappes; Sabine Riethdorf; Thomas Löning; Ana-Maria Bamberger
FosB is highly expressed in normal mammary epithelia, but down-regulated in poorly differentiated breast carcinomas.
Breast cancer research and treatment 2003;77(3):265-75.
2002: Ana-Maria Bamberger; Holger Kappes; Carola Methner; Gabriele Rieck; Jens Brümmer; Christoph Wagener; Thomas Löning; Karin Milde-Langosch
Expression of the adhesion molecule CEACAM1 (CD66a, BGP, C-CAM) in breast cancer is associated with the expression of the tumor-suppressor genes Rb, Rb2, and p27.
Virchows Archiv : an international journal of pathology 2002;440(2):139-44.
2001: Martin G Friedrich; C Blind; Karin Milde-Langosch; Andreas Erbersdobler; Stefan Conrad; Thomas Löning; Peter Hammerer; Hartwig Huland
Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.
European urology 2001;40(5):518-24.
2001: Ana-Maria Bamberger; Karin Milde-Langosch; T Löning; Christoph M Bamberger
The glucocorticoid receptor is specifically expressed in the stromal compartment of the human endometrium.
The Journal of clinical endocrinology and metabolism 2001;86(10):5071-4.
2001: Ana-Maria Bamberger; Karin Milde-Langosch; E Rössing; C Goemann; Thomas Löning
Expression pattern of the AP-1 family in endometrial cancer: correlations with cell cycle regulators.
Journal of cancer research and clinical oncology 2001;127(9):545-50.
2001: Karin Milde-Langosch; Ana-Maria Bamberger; C Goemann; E Rössing; Gabriele Rieck; B Kelp; Thomas Löning
Expression of cell-cycle regulatory proteins in endometrial carcinomas: correlations with hormone receptor status and clinicopathologic parameters.
Journal of cancer research and clinical oncology 2001;127(9):537-44.
2001: Karin Milde-Langosch; C Goemann; Carola Methner; Gabriele Rieck; Ana-Maria Bamberger; Thomas Löning
Expression of Rb2/p130 in breast and endometrial cancer: correlations with hormone receptor status.
British journal of cancer 2001;85(4):546-51.
2001: Karin Milde-Langosch; Sabine Riethdorf; A Kraus-Pöppinghaus; Lutz Riethdorf; Thomas Löning
Expression of cyclin-dependent kinase inhibitors p16MTS1, p21WAF1, and p27KIP1 in HPV-positive and HPV-negative cervical adenocarcinomas.
Virchows Archiv : an international journal of pathology 2001;439(1):55-61.
2001: Karin Milde-Langosch; Ana-Maria Bamberger; Gabriele Rieck; B Kelp; Thomas Löning
Overexpression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype.
Breast cancer research and treatment 2001;67(1):61-70.
2001: Holger Kappes; C Goemann; Ana-Maria Bamberger; Thomas Löning; Karin Milde-Langosch
PTEN expression in breast and endometrial cancer: correlations with steroid hormone receptor status.
Pathobiology : journal of immunopathology, molecular and cellular biology 2001;69(3):136-42.
2000: Sabine Riethdorf; Lutz Riethdorf; Karin Milde-Langosch; Tjoung-Won Park; Thomas Löning
Differences in HPV 16- and HPV 18 E6/E7 oncogene expression between in situ and invasive adenocarcinomas of the cervix uteri.
Virchows Archiv : an international journal of pathology 2000;437(5):491-500.
2000: Karin Milde-Langosch; Sabine Riethdorf; T Löning
Association of human papillomavirus infection with carcinoma of the cervix uteri and its precursor lesions: theoretical and practical implications.
Virchows Archiv : an international journal of pathology 2000;437(3):227-33.
2000: Karin Milde-Langosch; Ana-Maria Bamberger; Carola Methner; Gabriele Rieck; Thomas Löning
Expression of cell cycle-regulatory proteins rb, p16/MTS1, p27/KIP1, p21/WAF1, cyclin D1 and cyclin E in breast cancer: correlations with expression of activating protein-1 family members.
International journal of cancer. Journal international du cancer 2000;87(4):468-72.
2000: Ana-Maria Bamberger; Karin Milde-Langosch; Heinrich M Schulte; Thomas Löning
Progesterone receptor isoforms, PR-B and PR-A, in breast cancer: correlations with clinicopathologic tumor parameters and expression of AP-1 factors.
Hormone research 2000;54(1):32-7.
1999: Ana-Maria Bamberger; Carola Methner; BW Lisboa; C Städtler; Heinrich M Schulte; Thomas Löning; Karin Milde-Langosch
Expression pattern of the AP-1 family in breast cancer: association of fosB expression with a well-differentiated, receptor-positive tumor phenotype.
International journal of cancer. Journal international du cancer 1999;84(5):533-8.
1999: Ana-Maria Bamberger; Lutz Riethdorf; Karin Milde-Langosch; Christoph M Bamberger; I Thuneke; Insa Erdmann; Heinrich M Schulte; Thomas Löning
Strongly reduced expression of the cell cycle inhibitor p27 in endometrial neoplasia.
Virchows Archiv : an international journal of pathology 1999;434(5):423-8.
1999: Karin Milde-Langosch; Sabine Riethdorf; Tjoung-Won Park
[Natural course of HPV infection. Usefulness of HPV analysis in cervix diagnosis].
Der Pathologe 1999;20(1):15-24.
1999: Karin Milde-Langosch; Lutz Riethdorf; Ana-Maria Bamberger; Thomas Löning
P16/MTS1 and pRB expression in endometrial carcinomas.
Virchows Archiv : an international journal of pathology 1999;434(1):23-8.
1997: BW Lisboa; S Vogtländer; T Gilster; Lutz Riethdorf; Karin Milde-Langosch; Thomas Löning
Molecular and immunohistochemical analysis of p53 mutations in scrapings and tissue from preinvasive and invasive breast cancer.
Virchows Archiv : an international journal of pathology 1997;431(6):375-81.
1997: P Röhlke; Karin Milde-Langosch; C Weyland; U Pichlmeier; Walter Jonat; Thomas Löning
p53 is a persistent and predictive marker in advanced ovarian carcinomas: multivariate analysis including comparison with Ki67 immunoreactivity.
Journal of cancer research and clinical oncology 1997;123(9):496-501.
1996: Christian Hagel; G Laking; Rudolf Laas; S Scheil; R Jung; Karin Milde-Langosch; Dimitrios Stavrou
Demonstration of p53 protein and TP53 gene mutations in oligodendrogliomas.
European journal of cancer (Oxford, England : 1990) 1996;32A(13):2242-8.
1996: Lutz Riethdorf; C Begemann; Sabine Riethdorf; Karin Milde-Langosch; T Löning
Comparison of benign and malignant endometrial lesions for their p53 state, using immunohistochemistry and temperature-gradient gel electrophoresis.
Virchows Archiv : an international journal of pathology 1996;428(1):47-51.
1995: Karin Milde-Langosch; K Albrecht; S Joram; Horst H Schlechte; M Giessing; T Löning
Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva.
International journal of cancer. Journal international du cancer 1995;63(5):639-45.
1995: S Kappes; Karin Milde-Langosch; P Kressin; B Passlack; B Dockhorn-Dworniczak; P Röhlke; T Löning
p53 mutations in ovarian tumors, detected by temperature-gradient gel electrophoresis, direct sequencing and immunohistochemistry.
International journal of cancer. Journal international du cancer 1995;64(1):52-9.
1994: C Kühler-Obbarius; Karin Milde-Langosch; T Löning; H E Stegner
Polymerase chain reaction-assisted evaluation of low and high grade squamous intraepithelial lesion cytology and reappraisal of the Bethesda System.
Acta cytologica 1994;38(5):681-6.
1994: C Kühler-Obbarius; Karin Milde-Langosch; G Helling-Giese; A Salfelder; C Peimann; T Löning
Polymerase chain reaction-assisted papillomavirus detection in cervicovaginal smears: stratification by clinical risk and cytology reports.
Virchows Archiv : an international journal of pathology 1994;425(2):157-63.
1993: R B Scholz; Karin Milde-Langosch; R Jung; Horst H Schlechte; Hartmut Kabisch; C Wagener; T Löning
Rapid screening for Tp53 mutations by temperature gradient gel electrophoresis: a comparison with SSCP analysis.
Human molecular genetics 1993;2(12):2155-8.
1993: Karin Milde-Langosch; C Schreiber; G Becker; T Löning; H E Stegner
Human papillomavirus detection in cervical adenocarcinoma by polymerase chain reaction.
Human pathology 1993;24(6):590-4.
1992: T Brack; R B Scholz; Karin Milde-Langosch; S Heinsohn; T Löning; Hartmut Kabisch
Detection of N-myc gene amplification in bone marrow specimen of stage IV neuroblastoma patients.
Cancer detection and prevention 1992;16(3):185-92.
1992: P Kiene; Karin Milde-Langosch; M Runkel; K Schulz; T Löning
A simple and rapid technique to process formalin-fixed, paraffin-embedded tissues for the detection of viruses by the polymerase chain reaction.
Virchows Archiv. A, Pathological anatomy and histopathology 1992;420(3):269-73.
1991: Karin Milde-Langosch; C Wilckens; T Brack; T Löning
[Demonstration and biological significance of viral and cellular oncogenes in uterine carcinomas].
Verhandlungen der Deutschen Gesellschaft für Pathologie 1991;75():363-5.
1991: P Kiene; Karin Milde-Langosch; T Löning
Human papillomavirus infection in vulvar lesions of lichen sclerosus et atrophicus.
Archives of dermatological research 1991;283(7):445-8.
1989: R P Henke; I Guèrin-Reverchon; Karin Milde-Langosch; H S Koppang; T Löning
In situ detection of human papillomavirus types 13 and 32 in focal epithelial hyperplasia of the oral mucosa.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 1989;18(7):419-21.
1989: Karin Milde-Langosch; T Löning; M Meichsner; R P Henke
[HPV infections in tumors of the upper respiratory and digestive tract. In situ hybridization and dot-blot hybridization with biotinylated DNA probes].
Acta histochemica. Supplementband 1989;37():103-8.
1989: R P Henke; A Claviez; T Löning; G Rutter; Karin Milde-Langosch
[The immunogold-silver technic in detecting cellular nucleic acids and antigens in squamous epithelial cancers].
Acta histochemica. Supplementband 1989;37():73-8.
1987: R P Henke; Karin Milde-Langosch; T Löning; H S Koppang
Human papillomavirus type 13 and focal epithelial hyperplasia of the oral mucosa: DNA hybridization on paraffin-embedded specimens.
Virchows Archiv. A, Pathological anatomy and histopathology 1987;411(2):193-8.
1987: T Löning; M Meichsner; Karin Milde-Langosch; H Hinze; I Orlt; K Hörmann; K Sesterhenn; J Becker; P Reichart
HPV DNA detection in tumours of the head and neck: a comparative light microscopy and DNA hybridization study.
ORL; journal for oto-rhino-laryngology and its related specialties 1987;49(5):259-69.